Related Experiment Video
Updated: Jul 3, 2026

Standardization of Transfer across Labs between Flow Cytometers for Detection of Lymphocytes in Japanese Encephalitis Vaccinated Children
Published on: February 10, 2023
Cost-effectiveness of Japanese encephalitis (JE) immunization in Bali, Indonesia
Wei Liu1, John D Clemens, Komang Kari
1International Vaccine Institute, San 4-8, Bongcheon-7 dong, Kwanak-ku, Seoul 151-818, Republic of Korea.
Insights
A live, attenuated Japanese encephalitis (JE) vaccine program in Bali could prevent 54 cases and 5 deaths over 11 years. This immunization strategy is highly cost-effective, saving disability-adjusted life years (DALYs) at a low cost per case and DALY averted.
Area of Science:
- Epidemiology
- Public Health
- Vaccinology
Background:
- Japanese encephalitis (JE) poses a significant public health risk, particularly in endemic regions like Bali.
- Understanding the economic impact and effectiveness of vaccination programs is crucial for disease control.
Purpose of the Study:
- To model the cost-effectiveness of a live, attenuated JE vaccine immunization program in Bali.
- To estimate the potential impact of JE vaccination on disease incidence, mortality, and disability-adjusted life years (DALYs).
Main Methods:
- A hypothetical birth cohort of 100,000 newborns in Bali was modeled over 11 years.
- JE risk was estimated using cumulative incidence data from before vaccine introduction.
- Data on vaccine efficacy, vaccination, and treatment costs were sourced from published literature and surveys.
Main Results:
- The modeled immunization program averted an estimated 54 JE cases and 5 deaths.
- The program saved 1,224 disability-adjusted life years (DALYs).
- The net cost was USD 700 per JE case averted and USD 31 per DALY saved.
Conclusions:
- The live, attenuated JE vaccine program is a highly cost-effective intervention for preventing Japanese encephalitis in Bali.
- Vaccination significantly reduces disease burden, mortality, and disability, offering substantial public health benefits.
Abstract:
Two hypothetical birth cohorts in Bali, each consisting of 100,000 newborns, one immunized with live, attenuated JE vaccine and the other un-immunized, were modeled for JE risk over 11 years. Cumulative JE incidence before JE vaccine introduction was used to represent JE risk in the unvaccinated cohort. Data on vaccine efficacy, vaccination and treatment costs were taken from published papers and surveys. The potential immunization program averted 54 cases, 5 deaths and saved 1,224 disability adjusted life years (DALYs) at a net cost of USD 700 per JE case averted and USD 31 per DALY saved and thus was highly cost-effective.
More Related Videos
09:37Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
Published on: September 23, 2022
12:20Bacterial Artificial Chromosomes: A Functional Genomics Tool for the Study of Positive-strand RNA Viruses
Published on: December 29, 2015
Related Concept Videos
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology
Arboviral Encephalitis
Influenza
Enzyme-Linked Immunosorbent Assay
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or quantified.
American Trypanosomiasis